Bringing patient advocates, medical professionals, and other stakeholders together to help ensure that Floridians aren’t overpaying for prescription medicines.
Two generic oncological drugs may have been the cause of an estimated $1.5 billion in annual Medicare overspending, all because of a classification scheme exploited by the Big 3 #PBMs. https://t.co/b2guFA0mCZ
.@JamesUthmeierFL is launching a civil investigation into health care giant and #PBM CVS Caremark to see if the company is engaging in unfair market practices toward independent Florida pharmacies. Read more here: https://t.co/Pb3tweMDSH
The @WSJ ed board highlights how the #340B program has become a transfer of tens of billions of dollars a year from drug companies and patients to hospitals and their pharmacy partners. Patients aren't seeing the savings. We need #340Breform Read more: https://t.co/Se6EW0pTVN
Despite federal #PBMreforms looking to crackdown on profit-driven middlemen, #PBMs now look to make up lost revenue through new and inflated clinical services fees, continuing to artificially increase the cost of drugs for patients. Read more: https://t.co/btM86nBCV2
“Florida’s 2023 reforms were an important first step. But [...] the national conversation around #PBM reform continues to evolve” writes @PeterSchorschFL in new article from @Fla_Pol, highlighting the need to continue #PBMreform efforts. Read More: https://t.co/ELohFszenN
3 #PBMs dominate Medicaid Managed Care controlling almost 70% of retail prescriptions, new study from @USCSchaeffer finds, creating a highly concentrated market and illustrating why #PBMreform matters.
https://t.co/63DEytcjtv
"#PBMs’ anticompetitive and inflationary business practices are well-documented and lead to higher prices at the pharmacy counter." Op-ed in @RealClearHealth highlights the need for Congressional action on #PBMReform.https://t.co/TlyshWmGMT
A recent study highlighted in @statnews shows UnitedHealth pays its own #PBM affiliated physician groups 17% more than outside ones. Congress, it is time to break up these consolodated healthcare giants and pass real #PBMreform. Read more here: https://t.co/5N45H87JK8
"Insurers have crossed a line, and it’s time for Florida and the nation to push back." New op-ed from @DoctorDietrich highlights how insurers and #PBMs are getting in the way of the patient-provider relationship and impeding critical cancer care. https://t.co/ZostVeEe1O
Rising drug costs as a result of #PBM greed are harming patients and forcing independent pharmacies to shut down. Learn more about the #PBM reform policy solutions that can lower Rx drug costs for American patients here: https://t.co/3q3kqm2DTu
Employers face rising healthcare costs and specialty drug barriers. They have started to look for a strategic partner who’s transparent, proactive and is bringing solutions to them, changing the way the #PBM relationships are being formed. https://t.co/7w1CO1ulZE
Twelve #PBMs have been found in violation of a rule requiring adequate reimbursements to pharmacies in Arkansas. This is why accountability and transparency for drug pricing middlemen in every state is crucial. Congress must act now. https://t.co/PvGbl5Cm7h
“As #PBMs increasingly act in their own self-interest without transparency or accountability, drug prices rise and patients face health risks from cost prohibitive drug treatments," said @PresAmerMed. Congress take note, the time for #PBM reform is now. https://t.co/VZq4BYuCmL
New bipartisan legislation from @RepBuddyCarter would de-link #PBM revenue from the list price of drugs. This is a major step forward in protecting patients' fair access to prescription drugs. Learn more here: https://t.co/NztdKve4r3
New op-ed from @SarahHuckabee highlights her work in Arkansas in reining in #PBMs by banning anticompetetive practices that allowed #PBMs to dominate the Rx drug market. https://t.co/mhYW9swYJs
Florida is one key state that has implemented new #PBM regulations with a “sweeping and very aggressive #PBM reform bill.” Read more about state efforts aiming to bring more disclosure and transparency to PBM practices here: https://t.co/psJ7nnlH1p
"Congress should learn from Florida’s successful reforms and finally bring some relief to pharmacists and those we serve." New op-ed from Kevin Duane of @PanamaRxJax underscores why #PBMRefom can't wait. https://t.co/AYLijcZ8rk
14 biosimilars were excluded from #PBM controlled formularies in 2022. It’s clear PBM tactics are hindering patient access to these affordable treatment options. Let’s demand #PBMreform. https://t.co/VwmxlfQB57
The @FTC's lawsuit against the three largest #PBMs will continue after Chair Andrew Ferguson rejoins the case. This is a step in the right direction to hold #PBMs accountable. https://t.co/6qS4kU2JqN
Florida seniors & families deserve relief from #PBM middlemen. Congress: It’s time to lower prescription drug costs and put patients first. Pass the bipartisan PBM reforms that were agreed upon last year: https://t.co/FxdqilppeN